Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Tamoxifen's effectiveness in breast cancer patients strongly influenced by estrogen receptor status
January 5th, 2006
Physicians' assessments of tamoxifen's effectiveness in breast cancer patients was most strongly influenced by estrogen receptor status, not age. According to recent research published in the Journal of the American Geriatrics Society, "[The study's aim was] to examine physicians' assessments of tamoxifen effectiveness in breast cancer patients, identify predictors of these assessments, and estimate the relationship between these assessments and receipt of tamoxifen prescription. A cohort of breast cancer patients aged 65 and older at diagnosis and their physicians were surveyed using mailed questionnaires and telephone interviews." "[The...
Source: Women's Health Weekly (2006-01-05)
|
